|

Semaglutide Pen Injector [Ozempic] Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Ozempic, Semaglutide 1mg, Wegovy

Pipeline

Phase 1: 1Phase 4: 1

Top Sponsors

  • Woman's1
  • University of Maryland, Baltimore1

Indications

  • Diabetes2
  • Postpartum Disorder1
  • Pre Diabetes1
  • Diabetes Type 21
  • Obesity1

Baton Rouge, Louisiana1 trial

Treatment to Regress to Normoglycemia in Women with a Recent History of GDM

Woman's Hospital

Phase 4

Lancaster, Pennsylvania1 trial

Pharmacogenetics of Response to GLP1R Agonists

Amish Research Clinic

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.